BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 24388569)

  • 21. Dissecting clot retraction and platelet aggregation. Clot retraction does not require an intact fibrinogen gamma chain C terminus.
    Rooney MM; Parise LV; Lord ST
    J Biol Chem; 1996 Apr; 271(15):8553-5. PubMed ID: 8621481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antioxidant and antiaggregatory effects of an extract from Conyza canadensis on blood platelets in vitro.
    Olas B; Saluk-Juszczak J; Pawlaczyk I; Nowak P; Kolodziejczyk J; Gancarz R; Wachowicz B
    Platelets; 2006 Sep; 17(6):354-60. PubMed ID: 16973495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of superoxide anion in the inhibitory effect of SIN-1 in thrombin-activated human platelet adhesion.
    Cardoso MH; Morganti RP; Lilla S; Murad F; De Nucci G; Antunes E; Marcondes S
    Eur J Pharmacol; 2010 Feb; 627(1-3):229-34. PubMed ID: 19895807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peroxynitrite-induced changes of thiol groups in human blood platelets.
    Nowak P; Olas B; Bald E; Głowacki R; Wachowicz B
    Platelets; 2003 Sep; 14(6):375-9. PubMed ID: 14602551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of forskolin and cilostazol on clot retraction.
    Sannomiya Y; Tatsumi N; Okuda K
    Biochem Int; 1988 Dec; 17(6):1059-70. PubMed ID: 2854465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Platelet glucose metabolism and its function--energy dependency of fresh- and fixed-platelets in aggregation and clot retraction-- (author's transl)].
    Taketomi Y; Kuramoto A
    Nihon Ketsueki Gakkai Zasshi; 1976 Oct; 39(5):671-81. PubMed ID: 1037349
    [No Abstract]   [Full Text] [Related]  

  • 27. Reptilase clot retraction test. (Its cofactors and relation to other platelet functions).
    Kubisz P; Suranova J
    Pathol Biol (Paris); 1975 Apr; 23(4):269-75. PubMed ID: 1097991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential roles of fibrinogen and von Willebrand factor on clot formation and platelet adhesion in reconstituted and immune thrombocytopenia.
    Misgav M; Shenkman B; Budnik I; Einav Y; Martinowitz U
    Anesth Analg; 2011 May; 112(5):1034-40. PubMed ID: 21474661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of peroxynitrite on pig platelet lipid peroxidation and the secretory process induced by thrombin.
    Nowak P; Wachowicz B
    Cytobios; 2001; 106 Suppl 2():179-87. PubMed ID: 11545445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resveratrol, a natural phenolic compound may reduce carbonylation proteins induced by peroxynitrite in blood platelets.
    Olas B; Nowak P; Ponczek M; Wachowicz B
    Gen Physiol Biophys; 2006 Jun; 25(2):215-22. PubMed ID: 16917134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Similarities between platelet contraction and cellular motility during mitosis: role of platelet microtubules in clot retraction.
    Chao FC; Shepro D; Tullis JL; Belamarich FA; Curby WA
    J Cell Sci; 1976 May; 20(3):569-88. PubMed ID: 1270531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effects of D-glucaro-1,4-lactone against oxidative modifications in blood platelets.
    Saluk-Juszczak J; Olas B; Nowak P; Staroń A; Wachowicz B
    Nutr Metab Cardiovasc Dis; 2008 Jul; 18(6):422-8. PubMed ID: 17933501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal clot retraction, altered fibrin structure, and normal platelet function in multiple myeloma.
    Carr ME; Zekert SL
    Am J Physiol; 1994 Mar; 266(3 Pt 2):H1195-201. PubMed ID: 8160823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet function studies: clinical applications.
    McCormick KN
    J Fla Med Assoc; 1980 Feb; 67(2):113-6. PubMed ID: 7359100
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of different blood components on clot retraction analysed by measuring elasticity with a free oscillating rheometer.
    Tynngård N; Lindahl T; Ramström S; Berlin G
    Platelets; 2006 Dec; 17(8):545-54. PubMed ID: 17127482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasminogen, plasminogen activator, and platelets in the regulation of clot lysis. Reconstitution and patient studies.
    Carroll RC; Radcliffe RD; Taylor FB; Gerrard JM
    J Lab Clin Med; 1982 Dec; 100(6):986-96. PubMed ID: 6890569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concentration effects of platelets, fibrinogen and thrombin on platelet aggregation and fibrin clotting.
    Chao FC; Tullis JL; Kenney DM; Conneely GS; Doyle JR
    Thromb Diath Haemorrh; 1974 Sep; 32(1):216-31. PubMed ID: 4454041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aggregation of washed platelets from non-anticoagulated human blood is not reversible.
    Bowry SK; Müller-Berghaus G
    Thromb Haemost; 1986 Oct; 56(2):172-7. PubMed ID: 3101220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of fibrinogen concentration in severely ill patients on mechanical properties of whole blood clots.
    Dempfle CE; Kälsch T; Elmas E; Suvajac N; Lücke T; Münch E; Borggrefe M
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):765-70. PubMed ID: 19002042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the metabolism of human blood platelets in relation to clot retraction.
    BETTEX-GALLAND M; LUSCHER EF
    Thromb Diath Haemorrh; 1960 Mar; 4():178-95. PubMed ID: 13800197
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.